The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.

doi:10.1038/tpj.2013.15

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.

The pharmacogenomics journal - 1 Apr 2014

Absenger G, Benhaim L, Szkandera J, Zhang W, Yang D, Labonte M J, Pichler M, Stotz M, Samonigg H, Renner W, Gerger A, Lenz H-J

Abstract excerpt

Recent evidence indicates a potential prognostic and predictive value for germline polymorphisms in genes involved in cell cycle control. We investigated the effect of cyclin D1 (CCND1) rs9344 G>A in stage II/III colon cancer patients and validated the findings in an independent study cohort. For...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Colonic Neoplasms

Share to Cyclin D1

Share to Fluorouracil

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 23567490
DOI: 10.1038/tpj.2013.15

Genes

CCND1
TTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23567490-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.PMID 23567490Read ↗

The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.Semantic proximity Read ↗

The significant association of CCND1 genotypes with colorectal cancer in Taiwan.Semantic proximity Read ↗

The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.Semantic proximity Read ↗

Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.Semantic proximity Read ↗

An SNP Marker Predicts Colorectal Cancer Outcomes with 5-Fluorouracil-Based Adjuvant Chemotherapy Post-Resection.Semantic proximity Read ↗

Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with CetuximabSemantic proximity Read ↗

Integrative Bioinformatics Analysis: Unraveling Variant Signatures and Single-Nucleotide Polymorphism Markers Associated with 5-FU-Based Chemotherapy Resistance in Colorectal Cancer Patients.Semantic proximity Read ↗

Association between CCND1 rs9344 polymorphism and clinical prognosis of gastric cancerSemantic proximity Read ↗

Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.Semantic proximity Read ↗

CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.Semantic proximity Read ↗

SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.